Europe — EMA
Eribulina
Eribulin is a chemotherapy drug used to treat certain types of cancer. It works by slowing or stopping cancer cell growth, often used in advanced breast cancer
Request sourcing
What is Eribulin?
Eribulin is a chemotherapy drug used to treat certain types of cancer. It works by slowing or stopping cancer cell growth, often used in advanced breast cancer treatment.
What is Eribulin used for?
Eribulin is primarily used in the treatment of metastatic breast cancer. It may also be prescribed for other types of cancer, depending on medical history and treatment plans. The drug is administered intravenously and is typically used when other treatments have not been effective.
What are the side effects of Eribulin?
Common effects of Eribulin may include fatigue, nausea, and hair loss. Some patients may experience fever, constipation, or peripheral neuropathy. These effects can vary widely among individuals and should be discussed with a healthcare provider.
What precautions apply to Eribulin?
Eribulin should be handled with care, as it is a potent chemotherapy agent. It is important to follow all safety guidelines when administering the drug. Patients should be monitored for signs of infection or other complications during treatment.
What does Eribulin interact with?
Eribulin may interact with other medications, including those that affect liver function. It is important to inform healthcare providers about all current medications to avoid potential interactions. Alcohol and certain supplements may also affect the drug's efficacy.
